Introduction To date, COVID‐19 has claimed 4.9 million lives. Diabetes has been identified
as an independent risk factor of serious outcomes in people with COVID‐19 infection …

Purpose Infectious diseases are more frequent and can be associated with worse outcomes
in patients with diabetes. The aim of this study was to systematically review and conduct a …

Aims To estimate the prevalence of established diabetes and its association with the clinical
severity and in-hospital mortality associated with COVID-19. Data synthesis We …

Background Diabetes is a cardiometabolic comorbidity that may predispose COVID‐19
patients to worse clinical outcomes. This study sought to determine the prevalence of …

Background The coronavirus disease 2019 (COVID-19) patients with diabetes mellitus (DM)
are at high risk of fatal outcomes. This meta-analysis quantifies the prevalence of mortality …

Background: The mortality rate associated with Covid-19 varies considerably among studies
and determinants of this variability are not well characterized. Methods: A systematic review …

Background Many studies on COVID-19 have reported diabetes to be associated with
severe disease and mortality, however, the data is conflicting. The objectives of this meta …

Background & aims Coronavirus disease 2019 (COVID-19) spreads rapidly and within no
time, it has been declared a pandemic by the World Health Organization. Evidence suggests …

OBJECTIVE To describe the relationship between type 2 diabetes and all-cause mortality
among adults with coronavirus disease 2019 (COVID-19) in the critical care setting …

Globally, COVID-19 has become a major concern for the diabetic community. We conducted
a pooled analysis and constructed a forest plot for the association between diabetes and …